Increase access to Hydroxyurea for sickle cell management in Ghana
Stakeholders in the fight against sickle cell in the country have called for increased access to Hydroxyurea, a trademark drug for the management of the disease. Hydroxyurea, (a medication for reducing anemia in sickle cell patients), has become the most accessible Sickle Cell solution on the Ghanaian market, aiding an exponential extension of the lifespan […]
